Allotment is out. Check your result on the Anthem Biosciences IPO Allotment Status page.
Anthem Biosciences IPO logo

Anthem Biosciences IPO Subscription

Listed

Updated 21 July 2025, 9:15 AM IST· Mainboard

Anthem Biosciences IPO subscription closed on 16 July 2025 at 67.42x overall by shares. QIB demand came in at 192.80x, NII at 44.69x, and retail at 5.92x. See Retail, SHNI, and BHNI allotment chances in the table below.

Allotment date is 17 July 2025. Listing date on NSE and BSE is 21 July 2025.

Issue Price
Rs 570.00
GMP Today
Rs 179.00 (+31.40%)
Overall Sub
67.42x
Issue Size
₹3395.00 Cr
Allotment
17 Jul 2025
Listing
21 Jul 2025

Anthem Biosciences IPO Day-wise Subscription

Daily QIB, NII, Retail, and overall subscription as bids come in

DayQIBNIIRetailOverall
Day 1 - 14 Jul 20250.39x1.64x0.62x0.77x
Day 2 - 15 Jul 20250.62x10.26x2.21x3.48x
Day 3 - 16 Jul 2025192.80x44.69x5.92x67.39x

Anthem Biosciences IPO Allotment Chances

Retail, SHNI, and BHNI chances based on application subscription

Anthem Biosciences IPO allotment chances for Retail, SHNI, and BHNI. All three use lottery when the category is oversubscribed.

CategorySubscription (Apps)Allotment Chances
Retail5.92x (shares)Updating soon
SHNI (Rs 2L to Rs 10L)30.76x (shares)Updating soon
BHNI (above Rs 10L)51.66x (shares)Updating soon

Chances use application subscription (how many bids came in), not share or amount figures. If you get allotment, you get at least one lot. Higher subscription means lower chance per PAN.

Check the Anthem Biosciences IPO Allotment Status page from 17 July 2025 for your result.

Anthem Biosciences IPO Subscription by Amount

Category-wise subscription based on amount applied at issue price Rs 570.00

CategoryAmount OfferedAmount AppliedSubscription
QIBRs 677.35 CrRs 1,30,592.47 Cr192.80x
NIIRs 508.01 CrRs 22,703.49 Cr44.69x
sNII (Rs 2L to Rs 10L)Rs 169.34 CrRs 5,209.13 Cr30.76x
bNII (above Rs 10L)Rs 338.68 CrRs 17,494.36 Cr51.66x
RetailRs 1,185.36 CrRs 7,022.82 Cr5.92x
TotalRs 2,370.73 CrRs 1,60,318.78 Cr67.62x

Anthem Biosciences IPO Subscription by Shares

Category-wise subscription based on shares bid. Application-wise bid counts are not available for this IPO yet.

CategoryShares OfferedShares BidSubscription
QIB1,18,83,3342,29,10,95,976192.80x
NII89,12,50039,83,06,79244.69x
sNII (Rs 2L to Rs 10L)29,70,8339,13,88,25830.76x
bNII (above Rs 10L)59,41,66730,69,18,53451.66x
Retail2,07,95,83312,32,07,4225.92x
Total4,15,91,6672,81,26,10,19067.62x

What Do These Subscription Numbers Mean?

67.42x overall by shares means bids covered about 67 times the shares on offer. Allotment chances depend on applications in each category.

QIB at 192.80x by shares shows institutional demand from mutual funds, FIIs, and banks.

NII covers bids above Rs 2 lakh (44.69x by shares). SHNI and BHNI allotment is by lottery.

Retail at 5.92x by shares. Exact lottery chances need application data.

Anthem Biosciences IPO GMP After Subscription

GMP for Anthem Biosciences IPO stands at Rs 179.00 today, giving an estimated listing price of Rs 749.00 per share.

A subscription of 67.42x combined with a GMP of 31.40% is a strong combination heading into listing. QIB demand above 50x in particular tends to support listing sentiment, as institutional investors are seen as informed buyers.

Track live GMP on the Anthem Biosciences IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.

Anthem Biosciences IPO Key Dates

EventDate
IPO Open Date14 July 2025
IPO Close Date16 July 2025
Allotment Date17 July 2025
Refund Initiation18 July 2025
Share Credit to Demat18 July 2025
Listing Date21 July 2025
Minimum InvestmentRs 14,820.00
Lot Size26 shares

About Anthem Biosciences IPO

Anthem Biosciences is a technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) for drug discovery, development and manufacturing. It offers comprehensive CRDMO services across the New Chemical Entity (NCE) and New Biological Entity (NBE) lifecycles. The company also manufactures and sells Active Pharmaceutical Ingredients (APIs), including probiotics, enzymes, peptides, nutritional actives, vitamin analogues and biosimilars.

Understanding Subscription Categories

QIB - Qualified Institutional Buyers

Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.

NII - Non-Institutional Investors (SHNI & BHNI)

Investors bidding above Rs 2 lakh. Split into SHNI (Rs 2 lakh to Rs 10 lakh) and BHNI (above Rs 10 lakh). Both use lottery allotment when oversubscribed.

Retail - Retail Individual Investors

Investors bidding up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Winners get at least one lot.

Advertisement

Anthem Biosciences IPO Subscription FAQs

What is Anthem Biosciences IPO subscription status today?

Anthem Biosciences IPO subscription closed on 16 July 2025 with overall subscription of 67.42x (by shares) as of 27 August 2026, 4:32 AM IST. QIB 192.80x, NII 44.69x, Retail 5.92x.

What is the overall subscription of Anthem Biosciences IPO?

Anthem Biosciences IPO is subscribed 67.42x overall by shares at close on 16 July 2025. QIB 192.80x, NII 44.69x, and Retail 5.92x.

What is Anthem Biosciences IPO QIB subscription?

Anthem Biosciences IPO QIB (Qualified Institutional Buyers) subscription is 192.80x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.

What is Anthem Biosciences IPO Retail subscription?

Anthem Biosciences IPO Retail subscription is 5.92x by shares. Retail bids are up to Rs 2 lakh per PAN.

What is Anthem Biosciences IPO NII, SHNI, and BHNI subscription?

Anthem Biosciences IPO NII subscription is 44.69x by shares. NII is bids above Rs 2 lakh, split into SHNI (Rs 2L to Rs 10L) and BHNI (above Rs 10L).

What are Anthem Biosciences IPO retail allotment chances?

Anthem Biosciences IPO retail share subscription is 5.92x. Application data is needed for exact lottery chances.

What are Anthem Biosciences IPO SHNI allotment chances?

Anthem Biosciences IPO SHNI share subscription is 30.76x. Application data is needed for exact lottery chances.

What are Anthem Biosciences IPO BHNI allotment chances?

Anthem Biosciences IPO BHNI share subscription is 51.66x. Application data is needed for exact lottery chances.

When is Anthem Biosciences IPO allotment date?

Anthem Biosciences IPO allotment date is 17 July 2025. Check Anthem Biosciences IPO Allotment Status on IPOwiz from that day using your PAN.

When does Anthem Biosciences IPO subscription close?

Anthem Biosciences IPO subscription closed on 16 July 2025. No new applications are accepted after the close.

What is Anthem Biosciences IPO GMP today?

Anthem Biosciences IPO GMP is ₹179 today (+31.40% over issue price ₹570). See live GMP on the Anthem Biosciences IPO GMP Today page.

What is Anthem Biosciences IPO issue price and lot size?

Anthem Biosciences IPO issue price is ₹570 per share. Lot size is 26 shares. Minimum investment is ₹14,820 per lot. Issue size: ₹3395.00 Cr.

When is Anthem Biosciences IPO listing date?

Anthem Biosciences IPO listing date is 21 July 2025 on NSE and BSE. Allotment is on 17 July 2025.

How does subscription affect Anthem Biosciences IPO allotment?

In Anthem Biosciences IPO, Retail, SHNI, and BHNI allotment is by lottery when oversubscribed. Chances follow application subscription in each category, not share volume. At 67.42x overall, competition is very high.

For allotment results from 17 July 2025, visit the Anthem Biosciences IPO Allotment Status page. For listing day updates on 21 July 2025, download the IPOwiz App.

Sources

We match Anthem Biosciences IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.

  • SEBIRules for IPO allotment and disclosures in India
  • NSEExchange notices, bidding data, and listing updates
  • BSEExchange notices and IPO allotment check tools
  • RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
  • IPO RegistrarRegistrar details are on the allotment page for this IPO

Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.

Reviewed by

Dinesh Agrawal · Lead IPO Analyst

15+ years in Indian markets and IPO research. He reviews subscription data before it goes live.